Melittin Restores PTEN Expression by Down-Regulating HDAC2
in Human Hepatocelluar Carcinoma HepG2 Cells
PLoS One, 2014 May 2;9(5):e95520
Melittin is a water-soluble toxic peptide derived from the
venom of the bee. Although many studies show the anti-tumor activity of
melittin in human cancer including glioma cells, the underlying mechanisms
remain elusive. Here the effect of melittin on human hepatocelluar carcinoma
HepG2 cell proliferation in vitro and further mechanisms was investigated. We
found melittin could inhibit cell proliferation in vitro using Flow cytometry
and MTT method. Besides, we discovered that melittin significantly downregulated
the expressions of CyclinD1 and CDK4.
Results of western Blot and Real-time PCR analysis indicated
that melittin was capable to upregulate the expression of PTEN and attenuate
histone deacetylase 2 (HDAC2) expression. Further studies demonstrated that
knockdown of HDAC2 completely mimicked the effects of melittin on PTEN gene
expression. Conversely, it was that the potential utility of melittin on PTEN
expression was reversed in cells treated with a recombinant pEGFP-C2-HDAC2
plasmid. In addition, treatment with melittin caused a downregulation of Akt
phosphorylation, while overexpression of HDAC2 promoted Akt phosphorylation.
These findings suggested that the inhibitory of cell growth
by melittin might be led by HDAC2-mediated PTEN upregulation, Akt inactivation,
and inhibition of the PI3K/Akt signaling pathways.
No comments:
Post a Comment